102 related articles for article (PubMed ID: 21090682)
1. Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.
Soubhye J; Prévost M; Van Antwerpen P; Zouaoui Boudjeltia K; Rousseau A; Furtmüller PG; Obinger C; Vanhaeverbeek M; Ducobu J; Néve J; Gelbcke M; Dufrasne FO
J Med Chem; 2010 Dec; 53(24):8747-59. PubMed ID: 21090682
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.
Jantschko W; Furtmüller PG; Zederbauer M; Neugschwandtner K; Lehner I; Jakopitsch C; Arnhold J; Obinger C
Biochem Pharmacol; 2005 Apr; 69(8):1149-57. PubMed ID: 15794935
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
Aldib I; Soubhye J; Zouaoui Boudjeltia K; Vanhaeverbeek M; Rousseau A; Furtmüller PG; Obinger C; Dufrasne F; Nève J; Van Antwerpen P; Prévost M
J Med Chem; 2012 Aug; 55(16):7208-18. PubMed ID: 22793255
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors.
Soubhye J; Aldib I; Elfving B; Gelbcke M; Furtmüller PG; Podrecca M; Conotte R; Colet JM; Rousseau A; Reye F; Sarakbi A; Vanhaeverbeek M; Kauffmann JM; Obinger C; Nève J; Prévost M; Zouaoui Boudjeltia K; Dufrasne F; Van Antwerpen P
J Med Chem; 2013 May; 56(10):3943-58. PubMed ID: 23581551
[TBL] [Abstract][Full Text] [Related]
5. Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation.
Van Antwerpen P; Boudjeltia KZ; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Biochem Biophys Res Commun; 2005 Nov; 337(1):82-8. PubMed ID: 16171780
[TBL] [Abstract][Full Text] [Related]
6. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms.
Queiroz RF; Vaz SM; Augusto O
Biochem J; 2011 Nov; 439(3):423-31. PubMed ID: 21749327
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
[TBL] [Abstract][Full Text] [Related]
9. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.
Van Antwerpen P; Prévost M; Zouaoui-Boudjeltia K; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Dufrasne F
Bioorg Med Chem; 2008 Feb; 16(4):1702-20. PubMed ID: 18063373
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation.
Zouaoui Boudjeltia K; Moguilevsky N; Legssyer I; Babar S; Guillaume M; Delree P; Vanhaeverbeek M; Brohee D; Ducobu J; Remacle C
Biochem Biophys Res Commun; 2004 Dec; 325(2):434-8. PubMed ID: 15530411
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the binding and reactivity of plant and mammalian peroxidases to indole derivatives by computational docking.
Hallingbäck HR; Gabdoulline RR; Wade RC
Biochemistry; 2006 Mar; 45(9):2940-50. PubMed ID: 16503648
[TBL] [Abstract][Full Text] [Related]
12. Revealing binding sites for myeloperoxidase on the surface of human low density lipoproteins.
Sokolov AV; Chekanov AV; Kostevich VA; Aksenov DV; Vasilyev VB; Panasenko OM
Chem Phys Lipids; 2011 Jan; 164(1):49-53. PubMed ID: 21055395
[TBL] [Abstract][Full Text] [Related]
13. Role of the covalent glutamic acid 242-heme linkage in the formation and reactivity of redox intermediates of human myeloperoxidase.
Zederbauer M; Jantschko W; Neugschwandtner K; Jakopitsch C; Moguilevsky N; Obinger C; Furtmüller PG
Biochemistry; 2005 May; 44(17):6482-91. PubMed ID: 15850382
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid.
Allegra M; Furtmüller PG; Jantschko W; Zederbauer M; Tesoriere L; Livrea MA; Obinger C
Biochem Biophys Res Commun; 2005 Jul; 332(3):837-44. PubMed ID: 15913556
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.
Ohki I; Ishigaki T; Oyama T; Matsunaga S; Xie Q; Ohnishi-Kameyama M; Murata T; Tsuchiya D; Machida S; Morikawa K; Tate S
Structure; 2005 Jun; 13(6):905-17. PubMed ID: 15939022
[TBL] [Abstract][Full Text] [Related]
16. Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.
Aldib I; Gelbcke M; Soubhye J; Prévost M; Furtmüller PG; Obinger C; Elfving B; Alard IC; Roos G; Delporte C; Berger G; Dufour D; Zouaoui Boudjeltia K; Nève J; Dufrasne F; Van Antwerpen P
Eur J Med Chem; 2016 Nov; 123():746-762. PubMed ID: 27537923
[TBL] [Abstract][Full Text] [Related]
17. Redox thermodynamics of the Fe(III)/Fe(II) couple of human myeloperoxidase in its high-spin and low-spin forms.
Battistuzzi G; Bellei M; Zederbauer M; Furtmüller PG; Sola M; Obinger C
Biochemistry; 2006 Oct; 45(42):12750-5. PubMed ID: 17042493
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of oxygen binding to ferrous myeloperoxidase.
Jantschko W; Furtmüller PG; Zederbauer M; Jakopitsch C; Obinger C
Arch Biochem Biophys; 2004 Jun; 426(1):91-7. PubMed ID: 15130787
[TBL] [Abstract][Full Text] [Related]
19. The relationship between LDL oxidation and macrophage myeloperoxidase activity.
Wu J; Liu Y; Li X; Chen L; Xia L; Hong J
Chin Med J (Engl); 2003 May; 116(5):791-3. PubMed ID: 12875704
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-catalyzed taurine chlorination: initial versus equilibrium rate.
Ramos DR; Victoria García M; Canle L M; Arturo Santaballa J; Furtmüller PG; Obinger C
Arch Biochem Biophys; 2007 Oct; 466(2):221-33. PubMed ID: 17868637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
